PetraRietschelMDPhD

PubMed

• Response to Letter to the Editor.
  Tamta Makharadze, Miranda Gogishvili, Ana Baramidze, Siyu Li, Yuntong Li, Jean-Francois Pouliot, Frank Seebach, Israel Lowy, Giuseppe Gullo, Rietschel, P., Petra Riets...> ;Journal of Thoracic Oncology. 2023 Jul 1
• 2 citations
  Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
  Mahmut Gümüş, Chieh-I Chen, Cristina Ivanescu, Saadettin Kilickap, Igor Bondarenko, Mustafa Özgüroğlu, Miranda Gogishvili, Haci M Turk, Irfan Cicin, James Harnett, Ver...> ;Cancer. 2023 Jan 1
• 1 citations
  Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
  Ying Li, Matthew Brendel, Ning Wu, Wenzhen Ge, Hao Zhang, Ruben G W Quek, Jean-Francois Pouliot, Fei Wang, James Harnett, Rietschel, P., Petra Rietschel> ;Scientific Reports. 2022 Oct 21
• 1 citations
  Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer.
  Josephine Louella Feliciano, Dylan McLoone, Yingxin Xu, Ruben G W Quek, Andreas Kuznik, Jean-Francois Pouliot, Giuseppe Gullo, Patricia Guyot, Gerasimos Konidaris, Kei...> ;Frontiers in Oncology. 2022 Jan 1
• Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors ...
  Wenzhen Ge, Ning Wu, Jessica J Jalbert, Ruben G W Quek, Jinjie Liu, Petra Rietschel, Jean-Francois Pouliot, James Harnett, Melinda Laine Hsu, Josephine L Feliciano> ;Cancer Management and Research. 2022 Jan 1
• 1 citations
  Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50.
  Nick Freemantle, Yingxin Xu, Florence R Wilson, Patricia Guyot, Chieh-I Chen, Sam Keeping, Gerasimos Konidaris, Keith Chan, Andreas Kuznik, Kokuvi Atsou, Emily Glowien...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 9 citations
  Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data fr...
  Victor Moreno, Pilar Garrido, Kyriakos P. Papadopoulos, Maria Jose De Miguel Luken, Marta Gil-Martin, Raid Aljumaily, Lee S. Rosen, P. Rietschel, Kosalai Kal Mohan, Su...> ;Lung Cancer. 2021 May 1
• 7 citations
  Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies.
  Shigehisa Kitano, Toshio Shimizu, Takafumi Koyama, Takahiro Ebata, Satoru Iwasa, Shunsuke Kondo, Akihiko Shimomura, Yutaka Fujiwara, Noboru Yamamoto, Anne Paccaly, Siy...> ;Cancer Chemotherapy and Pharmacology. 2021 Jan 1
• 5 citations
  BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions.
  Jonathan B. Wallach, Petra Rietschel, Shalom Kalnicki, J.L. Fox> ;Practical Radiation Oncology. 2014 Sep 1
• 133 citations
  Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
  Gary K. Schwartz, William D. Tap, Li-Xuan Qin, Michael B. Livingston, Samir D. Undevia, Bartosz Chmielowski, Mark Agulnik, Scott M. Schuetze, Damon R. Reed, Scott H. O...> ;The Lancet. Oncology. 2013 Apr 1
• 52 citations
  Phase II Study of Extended-Dose Temozolomide in Patients With Melanoma
  Petra Rietschel, Susan E. Krown, Scott R. Gerst, Achim A. Jungbluth, Klaus J. Busam, Katherine Smith, Irene Orlow, Katherine S. Panageas, Paul B. Chapman> ;Journal of Clinical Oncology. 2008 May 10
• Phase II trial of extended-dosing temozolomide in patients with melanoma.
  Rietschel P, Ejadi S, Wolchok J, Krown S, Gerst S, Jungbluth AA, Busam K, Smith K, Panageas K, Chapman P> ;J. Clin. Oncol.. 2006-06-20
• 12 citations
  Immunotherapy of melanoma.
  Petra Rietschel, Paul B. Chapman> ;Hematology/oncology Clinics of North America. 2006 Jun 1
• 220 citations
  Variates of survival in metastatic uveal melanoma.
  Petra Rietschel, Katherine S. Panageas, Christine Hanlon, Ami Patel, David H. Abramson, Paul B. Chapman> ;Journal of Clinical Oncology. 2005 Nov 1
• Variates of survival for stage IV uveal melanoma.
  Rietschel P, Panageas K, Hanlon C, Patel A, Chapman PB> ;J. Clin. Oncol.. 2005-06-01
• 52 citations
  Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men
  Gary Meininger, Colleen Hadigan, Petra Rietschel, Steven K. Grinspoon> ;The American Journal of Clinical Nutrition. 2002 Aug 1
• 92 citations
  Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
  Jeannie S. Huang, Petra Rietschel, Colleen Hadigan, Daniel I. Rosenthal, Steven K. Grinspoon> ;AIDS. 2001 May 25
• 147 citations
  Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
  Petra Rietschel, Colleen Hadigan, Colleen Corcoran, Takara L. Stanley, Gregory Neubauer, Joseph M. Gertner, Steven K. Grinspoon> ;The Journal of Clinical Endocrinology and Metabolism. 2001 Feb 1
• 520 citations
  Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
  Colleen Hadigan, James B. Meigs, Colleen Corcoran, Petra Rietschel, Sarah Piecuch, Nesli Basgoz, Benjamin T. Davis, Paul E. Sax, Takara L. Stanley, Peter W.F. Wilson, ...> ;Clinical Infectious Diseases. 2001 Jan 1
• 97 citations
  Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
  Petra Rietschel, Colleen Corcoran, Takara L. Stanley, Nesli Basgoz, Anne Klibanski, Steven K. Grinspoon> ;Clinical Infectious Diseases. 2000 Nov 15
• Join now to see all